Company Advaxis, Inc. Nasdaq
Equities
US0076242082
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
- | - | ||
- | - | ||
50 | - | ||
- | - | ||
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 13-07-15 |
Roni Appel
CEO | Chief Executive Officer | 57 | 04-10-31 |
Murray Goldberg
BRD | Director/Board Member | 79 | 23-01-18 |
Robert Spiegel
BRD | Director/Board Member | 73 | 23-01-18 |
- | - | ||
Ken Berlin
CEO | Chief Executive Officer | 59 | 18-04-22 |
Director/Board Member | 53 | 23-01-18 | |
58 | - | ||
44 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.33% | 42.75B | |
+47.70% | 41.61B | |
+11.49% | 41.34B | |
-8.83% | 26.59B | |
+6.46% | 25.49B | |
-23.41% | 18.12B | |
+29.87% | 12.24B | |
-2.50% | 11.76B | |
+7.84% | 11B |